Endologix Reports Second Quarter 2015 Financial Results

Go back to Endologix Reports Second Quarter 2015 Financial Results

Piper Jaffray Cuts Price Target on Endologix (ELGX) to $20 Following 2Q15

August 4, 2015 8:29 AM EDT

Piper Jaffray maintained an Overweight rating on Endologix (NASDAQ: ELGX), and cut the price target to $20.00 (from $21.00), following 2Q15 results. Endologix reported revenues of $39.5M, just ahead of consensus $39.4M.

Analyst Brooks West commented, "Endologix reported 2Q15 revenues of $39.5M (+8%cc) just ahead... More

Canaccord Genuity Downgrades Endologix (ELGX) to Hold

August 4, 2015 7:03 AM EDT

Canaccord Genuity downgraded Endologix (NASDAQ: ELGX) from Buy to Hold with a price target of $14.00 (from $18.50).

For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.

Shares of Endologix closed at $14.06 yesterday.

... More

Endologix (ELGX) Misses Q2 EPS by 5c

August 3, 2015 4:08 PM EDT

Endologix (NASDAQ: ELGX) reported Q2 EPS of ($0.18), $0.05 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $39.5 million versus the consensus estimate of $39.35 million.

For earnings history and earnings-related data on Endologix (ELGX) click here.

... More